retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism Retatrutide: How GLP-1/GIP/Glucagon Receptor Agonism Differs From Existing Compounds Retatrutide is drawing major attention

SinghAKChaubeBZhangXSunJCitrinKMCanfran-DuqueAet alHepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice

2 Likes medgirl February 3, 2025, 6:00pm 19 I just had this alert through from the UKs Medicines and Healthcare Products Regulatory Agency: Screenshot_20250203-17571910801426 103 KB 5 Likes linguafood (Natascha) February 3, 2025, 6:07pm 20 One would hope that those who take these under the guidance of a medical professional are well-informed about this risk, and pause their meds in time for their procedures

Given the high prevalence of early -cell dysfunction and post-challenge dysglycaemia in this population, OGTT should be considered the diagnostic gold standard for diabetes and #prediabetes in Indians, especially in high-risk individuals

This is why conservative recommendations push the washout to 30 full days, particularly for those transitioning from higher tirzepatide doses